MY196687A - Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers - Google Patents

Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers

Info

Publication number
MY196687A
MY196687A MYPI2019005924A MYPI2019005924A MY196687A MY 196687 A MY196687 A MY 196687A MY PI2019005924 A MYPI2019005924 A MY PI2019005924A MY PI2019005924 A MYPI2019005924 A MY PI2019005924A MY 196687 A MY196687 A MY 196687A
Authority
MY
Malaysia
Prior art keywords
peptides
combination
present
scaffolds
cancers
Prior art date
Application number
MYPI2019005924A
Inventor
Anita Wiebe
Oliver Schoor
Jens Fritsche
Andrea Mahr
Toni Weinschenk
Harpreet Singh
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Priority to MYPI2019005924A priority Critical patent/MY196687A/en
Publication of MY196687A publication Critical patent/MY196687A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T-cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
MYPI2019005924A 2017-10-31 2017-10-31 Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers MY196687A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2019005924A MY196687A (en) 2017-10-31 2017-10-31 Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2019005924A MY196687A (en) 2017-10-31 2017-10-31 Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers

Publications (1)

Publication Number Publication Date
MY196687A true MY196687A (en) 2023-04-30

Family

ID=87761102

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2019005924A MY196687A (en) 2017-10-31 2017-10-31 Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers

Country Status (1)

Country Link
MY (1) MY196687A (en)

Similar Documents

Publication Publication Date Title
MX2017014008A (en) Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers.
PH12018500551A1 (en) Novel peptides and combination of peptides for use in immunotherapy against various cancers
MX2018009958A (en) Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers.
MX2017017145A (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers.
MX2021013147A (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers.
PH12019501377A1 (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
PH12019502308A1 (en) Peptides and combination thereof for use in the immunotherapy against cancers
MX2018011220A (en) Peptides and combination of peptides for use in immunotherapy against cancers.
PH12019502300A1 (en) Peptides and combination of peptides for use in immunotheraphy against leukemias and other cancers
PH12018502159A1 (en) Immunotheraphy against melanoma and other cancers
MY196837A (en) Novel peptides and combination of peptides for use in immunotherapy against various cancers
PH12020551958A1 (en) Peptides for use in immunotherapy against cancers
PH12017501994A1 (en) Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers
PH12018501639A1 (en) Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers
MY196396A (en) Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY196399A (en) Novel Peptides and Combination of Peptides and Scaffolds Thereof for use In Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY196687A (en) Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY196688A (en) Novel Peptides and Combination of Peptides and Scaffolds thereof for use in Immunotherapy Against Colorectal Carcinoma (CRC) and other Cancers
MY196395A (en) Novel Peptides and Combination of Peptides and Scaffolds Thereof For use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
MY197511A (en) Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (crc) and other cancers
PH12018502108A1 (en) Novel peptides and combination of peptides for use in immunotherapy against aml and other cancers
MY194834A (en) Novel Peptides and Combination of Peptides and Scaffolds for use In Immunotherapy Against Renal Cell Carcinoma (RCC) and other Cancers
MY197794A (en) Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers
MY197679A (en) Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers
MY197301A (en) Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc and other cancers